Figure 2 Corneal edema is reduced with AAV9- HA-Slc4a11 .  A,  Representative OCT images of  Slc4a11 +/+ ,  noninjected  Slc4a11 -/-  , and AAV9- HA-Slc4a11  injected  Slc4a11 -/-  eyes from young animals.  B,  Quantification of data from  A  (n = 4, 2 male and 2 female Slc4a11 +/+ , 2 male and 2 female  Slc4a11 -/-  animals were used).  C,  Representative OCT images of  Slc4a11 +/+ , noninjected  Slc4a11 -/ -  , and AAV9- HA-Slc4a11  injected  Slc4a11 -/-  eyes from older animals (n = 3–6, 2 male and 1 female Slc4a11 +/+ , 3 male and 3 female  Slc4a11 -/ -  animals were used).  D,  Quantification of data from  C . Mean ± standard deviation (SD). ns = not significant,  P  ≥ 0.1 (1-way ANOVA with Tukey’s multiple comparisons test). AAV9-HA = adeno-associated virus serotype 9 hemagglutinin; OD = right eye; OS = left eye.